Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Nature_of_Payment_or_Transfer_of_Value,Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Contextual_Information
35650,"SANOFI US SERVICES INC.",NJ,100000000067,23033.85,09/08/2014,"Cash or cash equivalent",188481118,"Consulting Fee","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14550.00,12/08/2014,"Cash or cash equivalent",188480666,"Consulting Fee","","","",""
35650,"Pfizer Inc.",NY,100000000286,14250.00,05/04/2015,"Cash or cash equivalent",323497432,"Consulting Fee","JENNIFER G ROBINSON","NON-COVERED PRODUCT","",""
35650,"Amgen Inc.",CA,100000000203,12500.00,02/19/2015,"Cash or cash equivalent",297465688,"Consulting Fee","",Repatha,"",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,11220.00,08/30/2014,"Cash or cash equivalent",188478770,"Consulting Fee","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9238.00,05/25/2015,"Cash or cash equivalent",318530890,"Consulting Fee","","","",""
35650,"SANOFI US SERVICES INC.",NJ,100000000067,8097.39,11/03/2014,"Cash or cash equivalent",188481120,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,6901.09,11/13/2013,"In-kind items and services",21553802,"Travel and Lodging","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6200.00,09/01/2014,"Cash or cash equivalent",188469746,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,5880.00,05/06/2014,"Cash or cash equivalent",188464674,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,4900.00,05/15/2015,"Cash or cash equivalent",319180813,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
35650,"Lilly USA, LLC",IN,100000000066,4380.00,06/09/2015,"Cash or cash equivalent",267870596,"Consulting Fee","","","",""
35650,"Amgen Inc.",CA,100000000203,4000.00,04/04/2014,"Cash or cash equivalent",138132250,"Consulting Fee","","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,3600.00,09/21/2015,"Cash or cash equivalent",330962270,"Consulting Fee","",Non-Product,"","Provided as part of a consulting engagement."
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,3060.00,08/11/2014,"Cash or cash equivalent",201962370,"Consulting Fee","",Non-Product,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,2800.00,08/13/2014,"Cash or cash equivalent",188814654,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,2800.00,01/28/2015,"Cash or cash equivalent",321412138,"Consulting Fee","","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,2400.00,11/18/2014,"Cash or cash equivalent",188480606,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,2200.00,02/06/2014,"Cash or cash equivalent",188814648,"Consulting Fee","","","",""
35650,"Amgen Inc.",CA,100000000203,2000.00,11/06/2014,"Cash or cash equivalent",138132274,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1867.71,08/27/2013,"Cash or cash equivalent",21552113,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1712.65,08/27/2013,"Cash or cash equivalent",21552114,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1634.25,08/27/2013,"Cash or cash equivalent",21552111,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1452.66,08/27/2013,"Cash or cash equivalent",21552112,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Eli Lilly and Company",IN,100000000088,1314.00,03/23/2015,"Cash or cash equivalent",267870588,"Consulting Fee","","","","SERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES"
35650,"Pfizer Inc.",NY,100000000286,1214.71,09/25/2013,"In-kind items and services",205651775,"Travel and Lodging","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1198.47,08/12/2014,"Cash or cash equivalent",188814770,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,1050.10,05/30/2014,"Cash or cash equivalent",188814694,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,988.68,05/15/2015,"In-kind items and services",319180848,"Travel and Lodging","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,957.67,12/08/2014,"In-kind items and services",188449890,"Travel and Lodging","","","",""
35650,"Amgen Inc.",CA,100000000203,942.38,10/09/2014,"In-kind items and services",138132292,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,864.52,08/04/2014,"In-kind items and services",188814636,"Travel and Lodging","","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,800.00,03/12/2014,"Cash or cash equivalent",201387722,"Consulting Fee","",Non-Product,"",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,800.00,12/01/2014,"Cash or cash equivalent",202549005,"Consulting Fee","",Non-Product,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,787.58,10/07/2014,"Cash or cash equivalent",188814856,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,787.58,07/10/2014,"Cash or cash equivalent",188814762,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,750.00,12/08/2014,"In-kind items and services",188449888,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,735.07,05/30/2014,"Cash or cash equivalent",188814690,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,717.58,09/09/2014,"Cash or cash equivalent",188814804,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,699.95,12/23/2015,"Cash or cash equivalent",321436362,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,689.09,07/31/2014,"In-kind items and services",202243838,"Travel and Lodging","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,674.74,04/15/2014,"Cash or cash equivalent",188814672,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,668.25,04/15/2014,"Cash or cash equivalent",188814668,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,667.61,12/23/2014,"Cash or cash equivalent",188814926,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,664.77,07/10/2014,"Cash or cash equivalent",188814758,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Lilly USA, LLC",IN,100000000066,661.20,06/04/2015,"In-kind items and services",267870592,"Travel and Lodging","","","",""
35650,"Pfizer Inc.",NY,100000000286,660.52,09/25/2013,"In-kind items and services",206076938,"Food and Beverage","","NONCOVERED PRODUCT","",""
35650,"Eli Lilly and Company",IN,100000000088,657.00,11/13/2015,"Cash or cash equivalent",267870586,"Consulting Fee","","","","SERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES"
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,653.57,09/10/2015,"Cash or cash equivalent",321414158,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,639.67,04/28/2014,"Cash or cash equivalent",138132268,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,632.14,04/14/2015,"Cash or cash equivalent",321413084,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,588.00,12/08/2014,"In-kind items and services",188481264,"Food and Beverage","","","",""
35650,"Amgen Inc.",CA,100000000203,583.37,03/27/2014,"In-kind items and services",138132260,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,553.13,09/10/2015,"Cash or cash equivalent",321414244,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,551.30,07/10/2014,"Cash or cash equivalent",188814756,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,551.30,10/07/2014,"Cash or cash equivalent",188814852,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,535.71,04/14/2015,"Cash or cash equivalent",321413090,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,518.11,07/10/2014,"Cash or cash equivalent",188814752,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,511.37,02/21/2014,"In-kind items and services",138132246,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,505.71,07/14/2015,"Cash or cash equivalent",321413808,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,505.71,07/14/2015,"Cash or cash equivalent",321413814,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,501.19,05/30/2014,"Cash or cash equivalent",188814688,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,501.19,04/15/2014,"Cash or cash equivalent",188814664,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,500.00,04/04/2014,"Cash or cash equivalent",138132248,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,488.05,07/10/2014,"Cash or cash equivalent",188814748,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,476.98,10/07/2014,"Cash or cash equivalent",188814842,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,459.42,07/10/2014,"Cash or cash equivalent",188814744,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,457.50,10/24/2015,"Cash or cash equivalent",321436268,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,428.70,10/09/2014,"In-kind items and services",138132284,"Travel and Lodging","","","",""
35650,"Amgen Inc.",CA,100000000203,427.14,10/09/2014,"In-kind items and services",138132290,"Travel and Lodging","","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,424.20,09/10/2015,"In-kind items and services",331130819,"Travel and Lodging","",Non-Product,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,402.27,08/13/2015,"Cash or cash equivalent",321414032,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,402.27,08/13/2015,"Cash or cash equivalent",321414056,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,402.27,09/10/2015,"Cash or cash equivalent",321414192,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,402.27,09/10/2015,"Cash or cash equivalent",321414196,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,400.00,03/30/2014,"Cash or cash equivalent",188453638,"Consulting Fee","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,378.88,07/10/2014,"Cash or cash equivalent",188814740,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,375.50,10/07/2014,"Cash or cash equivalent",188814850,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,363.70,10/11/2014,"In-kind items and services",138132288,"Travel and Lodging","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,357.18,05/25/2015,"Cash or cash equivalent",318531037,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,352.00,10/07/2014,"Cash or cash equivalent",188814810,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,349.09,12/23/2015,"Cash or cash equivalent",321436390,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,346.61,07/19/2014,"In-kind items and services",188814640,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,344.57,10/07/2014,"Cash or cash equivalent",188814838,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,344.57,09/09/2014,"Cash or cash equivalent",188814798,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,343.97,05/19/2015,"Cash or cash equivalent",321413188,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,331.88,12/23/2015,"Cash or cash equivalent",321436384,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,320.34,05/30/2014,"Cash or cash equivalent",188814684,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,311.30,06/16/2015,"Cash or cash equivalent",321413330,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,307.29,12/21/2013,"In-kind items and services",21553803,"Travel and Lodging","","","",""
35650,"Lilly USA, LLC",IN,100000000066,305.00,06/05/2015,"In-kind items and services",267870594,"Food and Beverage","","","","FOOD & BEVERAGE EXPENSES FOR A MEETING WHICH MAY HAVE INCLUDED MULTIPLE DAYS AND MAY HAVE HAD MULTIPLE MEALS PER DAY"
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,300.99,07/10/2014,"Cash or cash equivalent",188814738,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,290.47,11/20/2014,"Cash or cash equivalent",188814869,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,285.11,03/27/2014,"In-kind items and services",138132258,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,276.03,05/30/2014,"Cash or cash equivalent",188814681,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,273.71,12/08/2014,"In-kind items and services",188449892,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,268.61,11/17/2015,"Cash or cash equivalent",321436334,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,264.53,07/10/2014,"Cash or cash equivalent",188814734,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,263.79,05/15/2015,"In-kind items and services",319180870,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,261.43,07/14/2015,"Cash or cash equivalent",321413872,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,260.48,04/15/2014,"Cash or cash equivalent",188814660,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,252.86,06/16/2015,"Cash or cash equivalent",321413346,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,252.86,06/16/2015,"Cash or cash equivalent",321413350,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,249.08,12/23/2014,"Cash or cash equivalent",188814910,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,248.57,03/19/2015,"Cash or cash equivalent",321412640,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,248.57,03/17/2015,"Cash or cash equivalent",321412734,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,245.00,08/30/2014,"In-kind items and services",188407802,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,244.19,11/17/2015,"Cash or cash equivalent",321436332,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,237.69,08/13/2015,"Cash or cash equivalent",321413954,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,237.69,08/13/2015,"Cash or cash equivalent",321413960,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,236.86,08/30/2014,"Cash or cash equivalent",188407774,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,236.34,09/09/2014,"Cash or cash equivalent",188814794,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,231.64,08/15/2013,"In-kind items and services",8955948,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,221.25,11/17/2015,"Cash or cash equivalent",321436330,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,213.61,12/16/2014,"Cash or cash equivalent",188814894,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,202.88,10/10/2014,"In-kind items and services",138132280,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,196.07,08/13/2015,"Cash or cash equivalent",321413996,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,195.72,03/17/2015,"Cash or cash equivalent",321412624,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,191.60,12/23/2014,"Cash or cash equivalent",188814918,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,190.29,12/16/2014,"Cash or cash equivalent",188814904,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,186.43,04/14/2015,"Cash or cash equivalent",321413078,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,184.03,03/19/2015,"Cash or cash equivalent",321412612,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,184.03,03/17/2015,"Cash or cash equivalent",321412746,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,183.82,10/07/2014,"Cash or cash equivalent",188814806,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,181.87,08/12/2014,"Cash or cash equivalent",188814766,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,172.10,09/10/2015,"In-kind items and services",331130769,"Travel and Lodging","",Non-Product,"",""
35650,"Amgen Inc.",CA,100000000203,171.22,10/10/2014,"In-kind items and services",138132286,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,170.64,10/24/2015,"Cash or cash equivalent",321436276,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,170.46,12/23/2014,"Cash or cash equivalent",188814912,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,170.36,08/13/2015,"Cash or cash equivalent",321414026,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Lilly USA, LLC",IN,100000000066,169.86,06/05/2015,"In-kind items and services",267870590,"Travel and Lodging","","","","LODGING EXPENSES RELATED TO A MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS"
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,167.11,07/10/2014,"Cash or cash equivalent",188814728,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,165.76,07/10/2014,"Cash or cash equivalent",188814724,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Pfizer Inc.",NY,100000000286,163.13,09/25/2013,"In-kind items and services",205745134,"Travel and Lodging","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,160.91,07/14/2015,"Cash or cash equivalent",321413908,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,160.91,07/14/2015,"Cash or cash equivalent",321413915,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,155.40,12/16/2014,"Cash or cash equivalent",188814896,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,151.26,12/23/2015,"Cash or cash equivalent",321436386,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,150.00,08/11/2014,"In-kind items and services",201962374,"Travel and Lodging","",Non-Product,"",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,150.00,09/21/2015,"In-kind items and services",330962267,"Travel and Lodging","",Non-Product,"","Provided as part of a consulting engagement."
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,150.00,06/16/2015,"Cash or cash equivalent",321413368,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,147.00,09/10/2015,"In-kind items and services",331130763,"Travel and Lodging","",Non-Product,"",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,147.00,09/11/2015,"In-kind items and services",331130765,"Travel and Lodging","",Non-Product,"",""
35650,"Amgen Inc.",CA,100000000203,145.00,03/28/2014,"In-kind items and services",138132252,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,144.82,11/17/2015,"Cash or cash equivalent",321436316,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,140.63,06/16/2015,"Cash or cash equivalent",321413356,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Eli Lilly and Company",IN,100000000088,140.00,03/16/2015,"In-kind items and services",267870584,"Food and Beverage","","","","FOOD & BEVERAGE EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE INCLUDED MULTIPLE DAYS AND MAY HAVE HAD MULTIPLE MEALS PER DAY"
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,137.14,10/07/2014,"Cash or cash equivalent",188814816,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,135.94,11/17/2015,"Cash or cash equivalent",321436344,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,135.16,06/16/2015,"Cash or cash equivalent",321413340,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,135.00,07/31/2014,"In-kind items and services",202243824,"Travel and Lodging","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,131.46,09/10/2015,"Cash or cash equivalent",321414188,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,131.25,03/19/2015,"Cash or cash equivalent",321412666,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,131.25,03/17/2015,"Cash or cash equivalent",321412768,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,130.50,10/24/2015,"Cash or cash equivalent",321436292,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,130.00,08/01/2014,"In-kind items and services",202243800,"Travel and Lodging","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,128.25,09/09/2014,"Cash or cash equivalent",188814790,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,126.43,09/10/2015,"Cash or cash equivalent",321414144,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,124.42,08/14/2013,"In-kind items and services",8955947,"Food and Beverage","","","",""
35650,"Amgen Inc.",CA,100000000203,122.05,10/11/2014,"In-kind items and services",138132282,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,118.65,07/10/2014,"Cash or cash equivalent",188814720,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,118.64,10/24/2015,"Cash or cash equivalent",321436290,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,116.31,09/10/2015,"Cash or cash equivalent",321414138,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,113.57,07/14/2015,"Cash or cash equivalent",321413904,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,113.29,08/30/2014,"Cash or cash equivalent",188407776,"Travel and Lodging","","","",""
35650,"Pfizer Inc.",NY,100000000286,111.18,09/25/2013,"In-kind items and services",205503766,"Travel and Lodging","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,111.00,12/23/2014,"Cash or cash equivalent",188814924,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,110.63,10/24/2015,"Cash or cash equivalent",321436288,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,109.93,05/15/2015,"Cash or cash equivalent",319186986,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,107.83,12/16/2014,"Cash or cash equivalent",188814900,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,102.27,06/16/2015,"Cash or cash equivalent",321413362,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,100.00,08/30/2014,"Cash or cash equivalent",188478772,"Food and Beverage","","","",""
35650,"Amgen Inc.",CA,100000000203,99.60,03/27/2014,"In-kind items and services",138132254,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,99.49,07/19/2014,"In-kind items and services",188814646,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,98.82,04/14/2015,"Cash or cash equivalent",321413058,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,98.58,12/21/2013,"In-kind items and services",21552118,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,95.14,12/16/2014,"Cash or cash equivalent",188814907,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,94.50,03/19/2015,"Cash or cash equivalent",321412588,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Eli Lilly and Company",IN,100000000088,93.81,03/16/2015,"In-kind items and services",267870582,"Travel and Lodging","","","","GROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS"
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,93.75,10/24/2015,"Cash or cash equivalent",321436310,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,93.75,12/23/2015,"Cash or cash equivalent",321436404,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,93.75,03/19/2015,"Cash or cash equivalent",321412566,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,93.00,11/12/2014,"Cash or cash equivalent",138132276,"Food and Beverage","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,91.90,11/18/2014,"In-kind items and services",188482036,"Food and Beverage","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,90.60,05/15/2015,"In-kind items and services",319187035,"Travel and Lodging","","","",""
35650,"Amgen Inc.",CA,100000000203,89.60,03/30/2014,"In-kind items and services",138132256,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,88.16,09/24/2013,"Cash or cash equivalent",21552116,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,88.16,09/24/2013,"Cash or cash equivalent",21552117,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,86.33,07/29/2014,"In-kind items and services",188814656,"Food and Beverage","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,84.86,12/08/2014,"Cash or cash equivalent",188484722,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,82.29,11/20/2014,"Cash or cash equivalent",188814876,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,82.26,08/15/2013,"In-kind items and services",8955950,"Travel and Lodging","","","",""
35650,"Amgen Inc.",CA,100000000203,80.73,08/15/2013,"Cash or cash equivalent",8955949,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,80.51,03/17/2015,"Cash or cash equivalent",321412844,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,80.05,11/12/2014,"Cash or cash equivalent",138132278,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,79.71,06/16/2015,"Cash or cash equivalent",321413324,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,79.54,09/09/2014,"Cash or cash equivalent",188814784,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,79.40,07/10/2014,"Cash or cash equivalent",188814716,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,73.73,11/20/2014,"Cash or cash equivalent",188814866,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,73.71,07/10/2014,"Cash or cash equivalent",188814713,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,73.02,04/14/2015,"Cash or cash equivalent",321413034,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,72.13,09/24/2013,"Cash or cash equivalent",21552115,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,68.69,11/18/2014,"In-kind items and services",202814682,"Food and Beverage","",LIPTRUZET,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,67.79,12/21/2013,"In-kind items and services",21552119,"Food and Beverage","","","",""
35650,"Pfizer Inc.",NY,100000000286,67.70,11/16/2014,"In-kind items and services",207321052,"Food and Beverage","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,63.69,05/19/2015,"Cash or cash equivalent",321413194,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,62.23,07/10/2014,"Cash or cash equivalent",188814710,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,60.00,10/07/2014,"Cash or cash equivalent",188814824,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,57.69,12/23/2015,"Cash or cash equivalent",321436432,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,56.47,10/07/2014,"Cash or cash equivalent",188814831,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,56.43,04/28/2014,"Cash or cash equivalent",138132270,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,55.13,04/14/2015,"Cash or cash equivalent",321413046,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,54.00,07/10/2014,"Cash or cash equivalent",188814706,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,52.88,04/28/2014,"Cash or cash equivalent",138132266,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,52.24,08/13/2015,"Cash or cash equivalent",321413970,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,51.91,07/10/2014,"Cash or cash equivalent",188814704,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,51.24,08/01/2014,"In-kind items and services",202243834,"Food and Beverage","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,50.39,12/23/2014,"Cash or cash equivalent",188814914,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,50.29,11/20/2014,"Cash or cash equivalent",188814872,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,49.05,11/09/2015,"In-kind items and services",331185407,"Food and Beverage","",Non-Product,"",""
35650,"Pfizer Inc.",NY,100000000286,48.73,03/30/2014,"In-kind items and services",206135858,"Food and Beverage","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,47.57,12/23/2014,"Cash or cash equivalent",188814922,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,47.49,08/13/2015,"Cash or cash equivalent",321413964,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,46.88,11/17/2015,"Cash or cash equivalent",321436346,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,45.11,04/14/2015,"Cash or cash equivalent",321413052,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,39.96,09/10/2015,"In-kind items and services",331130815,"Food and Beverage","",Non-Product,"",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,39.70,08/30/2014,"In-kind items and services",188482022,"Food and Beverage","","","",""
35650,"Pfizer Inc.",NY,100000000286,39.39,08/31/2014,"In-kind items and services",206407036,"Food and Beverage","","NONCOVERED PRODUCT","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,39.06,09/10/2015,"In-kind items and services",331130811,"Food and Beverage","",Non-Product,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,37.98,07/10/2014,"Cash or cash equivalent",188814702,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,36.00,12/08/2014,"Cash or cash equivalent",188451526,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,36.00,11/20/2014,"Cash or cash equivalent",188814882,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,36.00,05/25/2015,"Cash or cash equivalent",318531013,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,35.52,05/30/2014,"Cash or cash equivalent",188814678,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,35.00,09/10/2015,"In-kind items and services",331130807,"Food and Beverage","",Non-Product,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,34.80,09/09/2014,"Cash or cash equivalent",188814780,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,34.09,05/19/2015,"Cash or cash equivalent",321413200,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,33.75,07/14/2015,"Cash or cash equivalent",321413848,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,33.75,07/14/2015,"Cash or cash equivalent",321413826,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,33.56,08/01/2014,"In-kind items and services",202243832,"Food and Beverage","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,33.00,07/14/2015,"Cash or cash equivalent",321413898,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,32.75,09/09/2014,"Cash or cash equivalent",188814776,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,32.25,07/10/2014,"Cash or cash equivalent",188814698,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,30.68,07/14/2015,"Cash or cash equivalent",321413836,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Merck Sharp & Dohme Corporation",NJ,100000000053,30.27,08/01/2014,"In-kind items and services",202243828,"Food and Beverage","",ZETIA,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,30.00,03/17/2015,"Cash or cash equivalent",321412860,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Pfizer Inc.",NY,100000000286,29.70,11/16/2014,"In-kind items and services",206550412,"Travel and Lodging","","NONCOVERED PRODUCT","",""
35650,"Pfizer Inc.",NY,100000000286,29.14,03/30/2014,"In-kind items and services",206217912,"Travel and Lodging","","NONCOVERED PRODUCT","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,28.29,05/19/2015,"Cash or cash equivalent",321413182,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,27.30,05/25/2015,"Cash or cash equivalent",318531027,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,26.26,11/20/2014,"Cash or cash equivalent",188814892,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Amgen Inc.",CA,100000000203,25.87,04/23/2014,"Cash or cash equivalent",138132262,"Travel and Lodging","","","",""
35650,"Lilly USA, LLC",IN,100000000066,24.15,06/17/2015,"Cash or cash equivalent",267870602,"Travel and Lodging","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,24.15,05/15/2015,"Cash or cash equivalent",319187002,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,23.57,04/14/2015,"Cash or cash equivalent",321413070,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,22.86,10/07/2014,"Cash or cash equivalent",188814812,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,22.86,08/13/2015,"Cash or cash equivalent",321413950,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,22.00,11/20/2014,"Cash or cash equivalent",188814880,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,22.00,09/09/2014,"Cash or cash equivalent",188814772,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Lilly USA, LLC",IN,100000000066,22.00,06/17/2015,"Cash or cash equivalent",267870598,"Travel and Lodging","","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,22.00,05/15/2015,"Cash or cash equivalent",319187019,"Travel and Lodging","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,20.71,11/20/2014,"Cash or cash equivalent",188814888,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,20.63,04/14/2015,"Cash or cash equivalent",321413064,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Amgen Inc.",CA,100000000203,17.62,04/23/2014,"Cash or cash equivalent",138132264,"Food and Beverage","","","",""
35650,"Amgen Inc.",CA,100000000203,14.16,10/28/2015,"In-kind items and services",297465690,"Food and Beverage","",Repatha,"",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,13.88,11/20/2014,"Cash or cash equivalent",188814860,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,10.29,03/17/2015,"Cash or cash equivalent",321412828,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,10.29,04/14/2015,"Cash or cash equivalent",321413040,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","PRALUENT (alirocumab) Injection","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,10.00,10/07/2014,"Cash or cash equivalent",188814820,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"Lilly USA, LLC",IN,100000000066,10.00,06/17/2015,"Cash or cash equivalent",267870600,"Travel and Lodging","","","",""
35650,"Amgen Inc.",CA,100000000203,9.61,08/15/2013,"Cash or cash equivalent",8955951,"Food and Beverage","","","",""
35650,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,9.41,10/07/2014,"Cash or cash equivalent",188814828,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Prime Medica","","",""
35650,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.08,05/25/2015,"Cash or cash equivalent",318530999,"Food and Beverage","","","",""
35650,"Amgen Inc.",CA,100000000203,3.60,11/09/2015,"In-kind items and services",297465686,"Food and Beverage","",Corlanor,"",""
35650,"Amgen Inc.",CA,100000000203,1.00,04/18/2014,"In-kind items and services",138132272,Education,"","","",""
